About Esperer Nutrition
Esperer Nutrition is a Healthcare company based in Mumbai (India) founded in 2018. Nutrition therapies for multiple cancer diseases are developed. Esperer Nutrition has raised $2.02 million across 4 funding rounds from investors including Zenfold, Shivshankar Gangaram Bangar and Nagesh Yarrabathina. The company has 18 employees. Esperer Nutrition was last valued at $5.19 million in December 2020. Its Indian entity Esperer Onco Nutrition Private Limited reported revenue of ₹5.32 Cr. Esperer Nutrition offers products and services including Es-Invigour, Es-Fortitude Nourish, Es-Fortitude Protect, RenVoitho HP, and Enorma PCOS. Its focus areas include Life Sciences, Nutraceuticals Tech, Dietary Supplements and Disease Specific. Its competitors include Kapiva, Setu and BBetter; 3 of its 3 listed competitors have raised funding.
Company details
Esperer Nutrition was founded in 2018 in Mumbai, India, within the nutraceuticals sector. Proprietary technology is utilized to create products addressing cancers and immunological disorders. EON therapy and ES fortitude nourishment are provided for various cancer types, alongside supplements for GI cancer and bone marrow transplant support. Additional offerings include nutrition for renal care and wound healing. Operations focus on therapeutic nutrition solutions.
- Headquarters Mumbai, India
- Employees 18
- Stage Minicorn
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website esperernutrition.com
- Social LinkedIn X Facebook
- Legal Name Esperer Onco Nutrition Private Limited
- Date of Incorporation 14 Mar, 2019
- Jurisdiction Navi Mumbai, Maharashtra, India
- Annual Revenue₹5.32 Cr
FY 2025 · +754% YoY
- Net Profit₹2.04 Cr
FY 2025 · 38% margin
- EBITDA₹2.23 Cr
FY 2025 · 42% margin
- Total Equity Funding$2.02M (USD)
in 4 rounds
- Latest Funding Round$124.25K (USD), Seed
Apr 2022
- InvestorsZenfold
& 2 more
- Employee Count18
Associated legal entities of Esperer Nutrition
Esperer Nutrition operates through Esperer Onco Nutrition Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Esperer Onco Nutrition Private Limited CIN U24299MH2019PTC322571 | Active | 14 Mar 2019 | Navi Mumbai, Maharashtra | ₹5.3 Cr | 18 | 5 | View details |
Products & Services of Esperer Nutrition
Esperer Nutrition offers a comprehensive portfolio of products and services, including Es-Invigour, Es-Fortitude Nourish, Es-Fortitude Protect, RenVoitho HP, and Enorma PCOS.
Nutritional therapy for managing cancer-induced malnutrition.
Supports nourishment and recovery during cancer treatment.
Provides protective nutritional support for cancer patients.
Nutritional aid for high-protein renal disease management.
Targets nutritional needs for PCOS condition management.
Supports postpartum health through specialized nutrition.
Funding Insights of Esperer Nutrition
Esperer Nutrition has successfully raised a total of $2.02M across 4 strategic funding rounds. The most recent funding activity was a Seed round of $124.25 thousand completed in April 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $2.02M
- Total Rounds 4
- Last Round Seed — $124,248
- Investors Count 3
All 4 funding rounds of Esperer Nutrition with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr 2022 | $124,248 | Seed | – | Zenfold | – |
| Dec 2020 | $1.24M | Seed | $5.19M | Zenfold | – |
| Apr 2020 | $659,255 | Seed | $3.81M | Zenfold | – |
| Mar 2020 | Seed | – | Shivshankar Gangaram Bangar |
| Date | Valuation | Stage |
|---|---|---|
| Dec 2020 | $5.19M | •••••••• |
| Apr 2020 | $3.81M | •••••••• |
Last known valuation $5.19M (Dec 2020). 3 investors in total: 1 institutional and 2 angel.
Investors in Esperer Nutrition
Esperer Nutrition has secured backing from 3 investors, including venture fund and angel investors. Prominent investors backing the company include Zenfold, Shivshankar Gangaram Bangar and Nagesh Yarrabathina.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Investment and venture building in high-growth areas, focusing on incubation and strategic partnerships. | 2017 | zenfold.in | Hyderabad, India | |
SG Shivshankar Gangaram Bangar | unknown_8f94ac154f91478d9 | |||
NY Nagesh Yarrabathina | unknown_06d7f4b020fe4e8ba |
Investor details for Esperer Nutrition
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Esperer Onco Nutrition Private Limited (Esperer Nutrition)
Esperer Onco Nutrition Private Limited is the primary company behind Esperer Nutrition. The board of Esperer Onco Nutrition Private Limited currently have 4 directors; the longest-serving is Raktim Chattopadhyay, appointed in 2019. 5 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Raktim Chattopadhyay DIN 08201473 | Director | 14 Mar 2019 | 7 yrs 7 mo | Esperer Onco Nutrition Private Limited |
| Sudipta Chattopadhyay DIN 08721831 | Director | 20 Dec 2023 | 2 yrs 10 mo | Esperer Onco Nutrition Private Limited |
| Sohilkumar Dahyabhai Tandel DIN 08201474 | Director | 08 Aug 2024 | 2 yrs 2 mo | Esperer Onco Nutrition Private Limited |
| Riddhesh Neema DIN 10877795 | Director | 20 Dec 2024 | 1 yr 10 mo | Esperer Onco Nutrition Private Limited |
Financials of Esperer Nutrition
Figures of Esperer Onco Nutrition Private Limited, the primary company behind Esperer Nutrition, for FY 2025. Revenue was ₹5.32 Cr (+754% year on year). Net profit was ₹2.04 Cr (38% margin). EBITDA was ₹2.23 Cr (42% margin). Revenue has grown at a compounded annual rate of -7% over three years and +81% over five years.
- ₹5.32 CrRevenue · FY 2025 · +754% YoY
- ₹2.04 CrNet profit · 38% margin
- ₹2.23 CrEBITDA · 42% margin
- ₹3.01 CrPaid-up capital
- 18Employees (provident fund records)
- -7%Revenue CAGR, 3 years
- +81%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Esperer Onco Nutrition Private Limited are on its company page.
Detailed financial statements for Esperer Nutrition
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Esperer Nutrition
4 dated milestones of Esperer Nutrition across 4 years, from founding to its latest funding, stage changes and deals.
- Founded Esperer Nutrition is founded.
- Funding First funding round.
- Milestone Reaches Minicorn status.
- Funding Latest funding round, Seed, of $124K.
Competitors of Esperer Nutrition
Esperer Nutrition has 3 listed competitors in our database, 3 of them funded. They include Kapiva, Setu and BBetter.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| kapiva.in | 2016 | Bengaluru, India | $77.85M | 492 | Ayurvedic healthcare and nutritional products are provided by Kapiva. | |
| setu.in | 2017 | Mumbai, India | $1.72M | 200 | Dietary supplements with herbal extracts and vitamins are provided. | |
| bbetter.co | 2018 | Hyderabad, India | $1.89M | 151 | Nutritional supplements are provided to enhance health and wellness. |
Detailed competitors of Esperer Nutrition
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Nutraceutical & Food-as-Medicine Platforms
3 companies that operate in the same segment as Esperer Nutrition (Nutraceutical & Food-as-Medicine Platforms) in India, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Ayurvedic healthcare and nutritional products are provided by Kapiva. | 2016 | Bengaluru, Karnataka, India | USD 77.85 M | USD 27.35 M | 362 | |
Nutritional supplements for multiple health ailments are developed. | 2005 | Mumbai, Maharashtra, India | USD 1.55 M | |||
Nutritional food and health supplements are provided by OZiva. | 2010 | Mumbai, Maharashtra, India | USD 17.32 M | USD 23.98 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Esperer Nutrition
Complete news archive for Esperer Nutrition
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Esperer Nutrition
Esperer Nutrition was founded in 2018 and raised its 1st funding round 2 years after it was founded.
Esperer Nutrition is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
Esperer Nutrition is a funded company, having raised a total of $2.02M across 4 funding rounds to date.
Esperer Nutrition has 18 employees.
The primary company behind Esperer Nutrition, Esperer Onco Nutrition Private Limited, reported revenue of ₹5.32 Cr for FY 2025, up 754% year on year.
Esperer Nutrition was founded in 2018 in Mumbai, India, within the nutraceuticals sector. Proprietary technology is utilized to create products addressing cancers and immunological disorders. EON therapy and ES fortitude nourishment are provided for various cancer types, alongside supplements for GI cancer and bone marrow transplant support. Additional offerings include nutrition for renal care and wound healing. Operations focus on therapeutic nutrition solutions.
Esperer Nutrition offers Es-Invigour, Es-Fortitude Nourish, Es-Fortitude Protect, RenVoitho HP, and 2 more products and services.
Esperer Nutrition has 3 investors. Key investors include Zenfold, Shivshankar Gangaram Bangar, and Nagesh Yarrabathina.
The valuation of Esperer Nutrition is $5.19M as of Dec 2020.
Esperer Nutrition operates through Esperer Onco Nutrition Private Limited.
The legal entities of Esperer Nutrition currently have 4 directors, including Sudipta Chattopadhyay, Raktim Chattopadhyay, Sohilkumar Dahyabhai Tandel and others.